Company Trinity Biotech plc

Equities

TRIB

US8964385046

Medical Equipment, Supplies & Distribution

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sales per region

Quarterly earnings - Rate of surprise

Sector Diagnostic & Testing Substances

Market Closed - Nasdaq Other stock markets 21:30:00 29/04/2024 BST			5-day change	1st Jan Change
1.78 ^USD	-2.73%		-1.66%	-17.02%

04-25	European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Thursday Trading	MT
04-23	European Equities Traded in the US as American Depositary Receipts Jump in Tuesday Trading	MT

Trinity Biotech PLC is an Ireland-based develops, acquires, manufactures and markets medical diagnostic systems, including both reagents and instrumentation for the clinical laboratory and point-of-care segments of the diagnostic market. The Company's products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes and disorders of the liver and intestine. Its segments include the Americas and Rest of World. It is a provider of raw materials to the life sciences and research industries globally. It also operates a licensed reference laboratory that specializes in diagnostics for autoimmune diseases. Its POC brands include Uni-Gold, Recombigen, MarDx, FlexTrans, Premier and Ultra. Its clinical laboratory brands include ImmuBlot, ImmuGlo, ImmuLisa, OTOblot and EZ. The Company manufactures kits for the detection of specialty and esoteric biomarkers of infectious diseases and other associated laboratory products.

Number of employees: 398

USD in Million	2021	Weight	2022	Weight	Delta
Clinical Laboratory Goods 78.0 %	75	80.4 %	58	78.0 %	-21.96%
Point-of-Care 12.3 %	10	11.1 %	9	12.3 %	-10.87%
Clinical Laboratory Services 9.7 %	8	8.5 %	7	9.7 %	-8.27%

USD in Million	2021	Weight	2022	Weight	Delta
Americas 67.5 %	67	72.3 %	51	67.5 %	-24.89%
Ireland 32.5 %	26	27.7 %	24	32.5 %	-5.62%

Managers	Title	Age	Since
John Gillard CEO	Chief Executive Officer	43	16/11/20
Ronan O'Caoimh FOU	Founder	68	31/05/92
Cormac Reynolds COO	Chief Operating Officer	-	31/12/20
Eibhlin Kelly CTO	Chief Tech/Sci/R&D Officer	40	31/08/15
Gary Keating CTO	Chief Tech/Sci/R&D Officer	51	30/09/22
Thomas Lindsay BRD	Director/Board Member	66	25/10/22
Jim Walsh BRD	Director/Board Member	65	01/10/95
Nick O’Hare SAM	Sales & Marketing	-	31/12/21
Colm Molloy HRO	Human Resources Officer	53	31/12/20
Ian Wells LAW	General Counsel	55	31/08/22

Members of the board	Title	Age	Since
Ronan O'Caoimh FOU	Founder	68	31/05/92
Jim Walsh BRD	Director/Board Member	65	01/10/95
Thomas Lindsay BRD	Director/Board Member	66	25/10/22
John Gillard CEO	Chief Executive Officer	43	16/11/20
Andrew Omidvar BRD	Director/Board Member	-	28/09/23

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	2	700,000	0	0	89.35 %
Stock B	1	33,077,257	30,181,196 ( 91.24 %)	2,511,200 ( 7.592 %)

Name	Equities	%	Valuation
Perceptive Advisors LLC 23.56 %	1,800,000	23.56 %	4 M $
Hunter Associates Investment Management LLC 4.255 %	325,180	4.255 %	663 367 $
Stonehill Capital Management LLC 3.960 %	302,595	3.960 %	617 294 $
Renaissance Technologies LLC 3.544 %	270,780	3.544 %	552 391 $
Acadian Asset Management LLC 1.793 %	136,976	1.793 %	279 431 $
Whitefort Capital Management, LP 1.072 %	81,903	1.072 %	167 082 $
Cambridge Investment Research, Inc. 0.2916 %	22,280	0.2916 %	45 451 $
NorthPointe Capital LLC 0.2638 %	20,160	0.2638 %	41 126 $
Becker Capital Management, Inc. 0.2356 %	18,000	0.2356 %	36 720 $
William Blair Capital Management LLC 0.1182 %	9,031	0.1182 %	18 423 $

Name	Equities	%	Valuation
MiCo IVD Holdings, LLC 53.53 %	44,759,388	53.53 %	23 M $
Ronan O'Caoimh 11.63 %	9,724,160	11.63 %	5 M $
Jim Walsh 1.667 %	1,393,612	1.667 %	710 742 $
Terence Dunne 0.000000 %	0	0.000000 %	- $
John Gillard 0.000000 %	0	0.000000 %	- $
Aris Kekedjian 0.000000 %	0	0.000000 %	- $

Trinity Biotech Plc

IDA Business Park

10, Bray

+353 1 276 9800

http://www.trinitybiotech.com

Company calendar

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Medical Equipment, Supplies & Distribution

Diagnostic & Testing Substances

	1st Jan change	Capi.
TRINITY BIOTECH PLC	-17.02%	17.28M
BIOMÉRIEUX	+1.69%	12.8B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	-7.57%	7.61B
DIASORIN S.P.A.	+3.22%	5.41B
AUTOBIO DIAGNOSTICS CO., LTD.	+0.93%	4.51B
LANTHEUS HOLDINGS, INC.	+8.48%	4.49B
ANDON HEALTH CO., LTD.	+9.21%	2.73B
VITROLIFE AB	-13.87%	2.02B
GUANGZHOU WONDFO BIOTECH CO.,LTD	-11.63%	1.73B
MYRIAD GENETICS, INC.	+3.45%	1.64B

Diagnostic & Testing Substances